CSS LLC’s Five Prime Therapeutics FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-10,600
Closed -$400K – 1293
2021
Q1
$400K Buy
+10,600
New +$264K 0.02% 630

CSS LLC's FPRX Position: Q2 2021 in Review

CSS LLC sold out of Five Prime Therapeutics (FPRX) in Q2 2021, closing a stake of 46,582 shares — an estimated $1.76M sold.

CSS LLC first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $1.76M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • CSS LLC reported no remaining Five Prime Therapeutics position as of Q2 2021 after selling out during the quarter.
  • CSS LLC sold 46,582 Five Prime Therapeutics shares in Q2 2021, an estimated $1.76M.
  • CSS LLC first reported a position in Five Prime Therapeutics in Q1 2021 and held it in 1 quarter.
  • CSS LLC's Five Prime Therapeutics position peaked at $1.76M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.